Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna Vassall, PhD"'
Autor:
Dr Stéphane Verguet, PhD, Carlos Riumallo-Herl, ScD, Gabriela B Gomez, PhD, Nicolas A Menzies, PhD, Rein M G J Houben, PhD, Tom Sumner, PhD, Marek Lalli, MSc, Richard G White, PhD, Prof Joshua A Salomon, PhD, Ted Cohen, DPH, Nicola Foster, MPH, Susmita Chatterjee, PhD, Sedona Sweeney, MSc, Inés Garcia Baena, MSc, Knut Lönnroth, PhD, Diana E Weil, MSc, Anna Vassall, PhD
Publikováno v:
The Lancet Global Health, Vol 5, Iss 11, Pp e1123-e1132 (2017)
Background: The economic burden on households affected by tuberculosis through costs to patients can be catastrophic. WHO's End TB Strategy recognises and aims to eliminate these potentially devastating economic effects. We assessed whether aggressiv
Externí odkaz:
https://doaj.org/article/da2b47b214854b679354e6af7793cdf6
Autor:
Dr. Rein M G J Houben, PhD, Nicolas A Menzies, PhD, Tom Sumner, PhD, Grace H Huynh, PhD, Nimalan Arinaminpathy, PhD, Jeremy D Goldhaber-Fiebert, PhD, Hsien-Ho Lin, PhD, Chieh-Yin Wu, MS, Sandip Mandal, PhD, Surabhi Pandey, PhD, Sze-chuan Suen, MS, Eran Bendavid, MD, Andrew S Azman, PhD, David W Dowdy, PhD, Nicolas Bacaër, PhD, Allison S Rhines, PhD, Prof. Marcus W Feldman, PhD, Andreas Handel, PhD, Prof. Christopher C Whalen, MD, Stewart T Chang, PhD, Bradley G Wagner, PhD, Philip A Eckhoff, PhD, James M Trauer, PhD, Justin T Denholm, PhD, Prof. Emma S McBryde, PhD, Ted Cohen, DPH, Prof. Joshua A Salomon, PhD, Carel Pretorius, PhD, Marek Lalli, MSc, Jeffrey W Eaton, PhD, Delia Boccia, PhD, Mehran Hosseini, MD, Gabriela B Gomez, PhD, Suvanand Sahu, MD, Colleen Daniels, MA, Lucica Ditiu, MD, Daniel P Chin, MD, Lixia Wang, MS, Vineet K Chadha, MD, Kiran Rade, MPhil, Puneet Dewan, MD, Piotr Hippner, MSc, Salome Charalambous, PhD, Prof. Alison D Grant, Prof. Gavin Churchyard, PhD, Yogan Pillay, PhD, L David Mametja, MPH, Michael E Kimerling, MD, Anna Vassall, PhD, Richard G White, PhD
Publikováno v:
The Lancet Global Health, Vol 4, Iss 11, Pp e806-e815 (2016)
Background: The post-2015 End TB Strategy proposes targets of 50% reduction in tuberculosis incidence and 75% reduction in mortality from tuberculosis by 2025. We aimed to assess whether these targets are feasible in three high-burden countries with
Externí odkaz:
https://doaj.org/article/f587d60093cc4ec18c3414ec3e0a14db
Autor:
Prof. Nicolas A Menzies, PhD, Gabriela B Gomez, PhD, Fiammetta Bozzani, MSc, Susmita Chatterjee, PhD, Nicola Foster, MPH, Ines Garcia Baena, MSc, Yoko V Laurence, MSc, Prof. Sun Qiang, PhD, Andrew Siroka, PhD, Sedona Sweeney, MSc, Stéphane Verguet, PhD, Nimalan Arinaminpathy, DPhil, Andrew S Azman, PhD, Eran Bendavid, MD, Stewart T Chang, PhD, Prof. Ted Cohen, DPH, Justin T Denholm, PhD, David W Dowdy, MD, Philip A Eckhoff, PhD, Jeremy D Goldhaber-Fiebert, PhD, Andreas Handel, PhD, Grace H Huynh, PhD, Marek Lalli, MSc, Hsien-Ho Lin, ScD, Sandip Mandal, PhD, Emma S McBryde, PhD, Surabhi Pandey, PhD, Prof. Joshua A Salomon, PhD, Sze-chuan Suen, MS, Tom Sumner, PhD, James M Trauer, MBBS, Bradley G Wagner, PhD, Prof. Christopher C Whalen, MD, Chieh-Yin Wu, MS, Delia Boccia, PhD, Vineet K Chadha, MD, Salome Charalambous, PhD, Daniel P Chin, MD, Prof. Gavin Churchyard, PhD, Colleen Daniels, MA, Puneet Dewan, MD, Lucica Ditiu, MD, Jeffrey W Eaton, PhD, Prof. Alison D Grant, PhD, Piotr Hippner, MSc, Mehran Hosseini, MD, David Mametja, MPH, Carel Pretorius, PhD, Yogan Pillay, PhD, Kiran Rade, MD, Suvanand Sahu, MD, Lixia Wang, MS, Rein M G J Houben, PhD, Michael E Kimerling, MD, Richard G White, PhD, Anna Vassall, PhD
Publikováno v:
The Lancet Global Health, Vol 4, Iss 11, Pp e816-e826 (2016)
Background: The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by 50% and mortality by 75% by 2025. We aimed to assess resource requirements and cost-effectiveness of strategies to achieve these targets in China, Ind
Externí odkaz:
https://doaj.org/article/3a2c5023c2c043b786c2c7197ab9fc55
Autor:
Dr. Gavin J Churchyard, PhD, Wendy S Stevens, FCPath, Lerole D Mametja, MPH, Kerrigan M McCarthy, FCPath, Violet Chihota, PhD, Mark P Nicol, FCPath, Linda K Erasmus, MMed, Norbert O Ndjeka, MMed, Lindiwe Mvusi, MBBCh, Anna Vassall, PhD, Edina Sinanovic, PhD, Helen S Cox, PhD, Christopher Dye, DPhil, Alison D Grant, PhD, Katherine L Fielding, PhD
Publikováno v:
The Lancet Global Health, Vol 3, Iss 8, Pp e450-e457 (2015)
Background: In South Africa, sputum smear microscopy has been replaced with Xpert MTB/RIF as the initial diagnostic test for tuberculosis. In a pragmatic parallel cluster-randomised trial, we evaluated the effect on patient and programme outcomes. Me
Externí odkaz:
https://doaj.org/article/eacfbe8b00db4fe89de9804e06528a23
Autor:
Prof Anna Vassall, PhD, Mariana Siapka, MSc, Nicola Foster, MSc, Lucy Cunnama, MSc, Lebogang Ramma, MSc, Prof Katherine Fielding, PhD, Kerrigan McCarthy, MSc, Prof Gavin Churchyard, PhD, Prof Alison Grant, PhD, Edina Sinanovic, PhD
Publikováno v:
The Lancet Global Health, Vol 5, Iss 7, Pp e710-e719 (2017)
Background: In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, received a conditional programmatic recommendation from WHO. Several model-based economic evaluations predicted that Xpert would be cost-effective across sub-Saharan Africa. W
Externí odkaz:
https://doaj.org/article/c6c6586f297945ce9d2ac25c4622eb8b
Autor:
Dr. Anna Vassall, PhD, Michael Pickles, PhD, Sudhashree Chandrashekar, MBBS, Marie-Claude Boily, PhD, Govindraj Shetty, BCom, Lorna Guinness, PhD, Catherine M Lowndes, PhD, Janet Bradley, MA, Prof. Stephen Moses, MD, Prof. Michel Alary, MD, Prof. Peter Vickerman, DPhil
Publikováno v:
The Lancet Global Health, Vol 2, Iss 9, Pp e531-e540 (2014)
Background: Avahan is a large-scale, HIV preventive intervention, targeting high-risk populations in south India. We assessed the cost-effectiveness of Avahan to inform global and national funding institutions who are considering investing in worldwi
Externí odkaz:
https://doaj.org/article/8f986136a93e41d8903d3d0d8ecff1ca